Why SpringWorks Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) surged in pre-market trading after the company reported the FDA approval of OGSIVEO (nirogacestat) as the first and only treatment for adults with desmoid tumors.

SpringWorks Therapeutics shares rose 14.4% to $23.77 in pre-market trading

Here are some other stocks moving in pre-market trading.

Gainers

Losers

 

Now Read This: Intuit, NetApp And 3 Stocks To Watch Heading Into Tuesday

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.